Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graeme Suthers

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Paediatrics and Child Health|December 5, 2022
Using a bedside test to detect genetic susceptibility to aminoglycoside-induced hearing loss: Has the future arrived?Meryta L May, Joshua Osowicki, Duaa Gaafar, et al.
Clinical & Experimental Ophthalmology|October 1, 2003
Sarcoma and familial retinoblastomaCelia S Chen, Graeme Suthers, Jacqueline Carroll, et al.
Carcinogenesis|September 16, 2005
Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiencySasja Beetstra, Carolyn Salisbury, Julie Turner, et al.
Cancer Letters|November 4, 2006
Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposisHaibo Bai, Scott Grist, Justin Gardner, et al.
Pathology|January 31, 2003
Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumoursAndrew Ruszkiewicz, Graeme Bennett, James Moore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 10, 2008
Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancerSasja Beetstra, Graeme Suthers, Varinderpal Dhillon, et al.
Genetic Testing and Molecular Biomarkers|January 25, 2011
"For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancerClaire E Wakefield, Paboda Ratnayake, Bettina Meiser, et al.
Familial Cancer|September 30, 2010
An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutationsPaboda Ratnayake, Claire E Wakefield, Bettina Meiser, et al.
Gastroenterology|May 12, 2005
Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancerDaniel L Worthley, Michael D Walsh, Melissa Barker, et al.
JAMA Oncology|July 17, 2015
Mosaic Epigenetic Inheritance as a Cause of Early-Onset Colorectal CancerMathew A Sloane, Andrea C Nunez, Deborah Packham, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Paediatrics and Child Health|December 5, 2022
Using a bedside test to detect genetic susceptibility to aminoglycoside-induced hearing loss: Has the future arrived?Meryta L May, Joshua Osowicki, Duaa Gaafar, et al.
Clinical & Experimental Ophthalmology|October 1, 2003
Sarcoma and familial retinoblastomaCelia S Chen, Graeme Suthers, Jacqueline Carroll, et al.
Carcinogenesis|September 16, 2005
Lymphocytes of BRCA1 and BRCA2 germ-line mutation carriers, with or without breast cancer, are not abnormally sensitive to the chromosome damaging effect of moderate folate deficiencySasja Beetstra, Carolyn Salisbury, Julie Turner, et al.
Cancer Letters|November 4, 2006
Functional characterization of human MutY homolog (hMYH) missense mutation (R231L) that is linked with hMYH-associated polyposisHaibo Bai, Scott Grist, Justin Gardner, et al.
Pathology|January 31, 2003
Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumoursAndrew Ruszkiewicz, Graeme Bennett, James Moore, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 10, 2008
Methionine-dependence phenotype in the de novo pathway in BRCA1 and BRCA2 mutation carriers with and without breast cancerSasja Beetstra, Graeme Suthers, Varinderpal Dhillon, et al.
Genetic Testing and Molecular Biomarkers|January 25, 2011
"For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancerClaire E Wakefield, Paboda Ratnayake, Bettina Meiser, et al.
Familial Cancer|September 30, 2010
An exploration of the communication preferences regarding genetic testing in individuals from families with identified breast/ovarian cancer mutationsPaboda Ratnayake, Claire E Wakefield, Bettina Meiser, et al.
Gastroenterology|May 12, 2005
Familial mutations in PMS2 can cause autosomal dominant hereditary nonpolyposis colorectal cancerDaniel L Worthley, Michael D Walsh, Melissa Barker, et al.
JAMA Oncology|July 17, 2015
Mosaic Epigenetic Inheritance as a Cause of Early-Onset Colorectal CancerMathew A Sloane, Andrea C Nunez, Deborah Packham, et al.
Pageof 3